Australia Patent: Syracuse University, Xeragenx File Application for 'Pharmaceutical formulations and methods for delivering a therapeutic, diagnostic, or imaging agent to CD206'

Press/Media: Expert Comment

PeriodDec 17 2021

Media coverage

1

Media coverage

  • TitleAustralia Patent: Syracuse University, Xeragenx File Application for 'Pharmaceutical formulations and methods for delivering a therapeutic, diagnostic, or imaging agent to CD206'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date12/17/21
    PersonsRobert Patrick Doyle